These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 6417042
21. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. Naruse K, Nakamura J, Hamada Y, Nakayama M, Chaya S, Komori T, Kato K, Kasuya Y, Miwa K, Hotta N. Exp Eye Res; 2000 Sep; 71(3):309-15. PubMed ID: 10973739 [Abstract] [Full Text] [Related]
22. Effect of aldose reductase inhibitors on the progression of retinopathy in galactose-fed dogs. Akagi Y, Kador PF. Exp Eye Res; 1990 Jun; 50(6):635-9. PubMed ID: 2115453 [Abstract] [Full Text] [Related]
23. [Comparison of aldose reductase in human cataractous lens and placenta]. Yoshida H, Miyata M. Nippon Ganka Gakkai Zasshi; 1982 Jun; 86(9):1370-8. PubMed ID: 6818855 [No Abstract] [Full Text] [Related]
24. Immunohistochemical localization of aldose reductase. II. Rat eye and kidney. Ludvigson MA, Sorenson RL. Diabetes; 1980 Jun; 29(6):450-9. PubMed ID: 6769730 [Abstract] [Full Text] [Related]
28. Distribution of aldose reductase in ocular tissues. Kern TS, Engerman RL. Exp Eye Res; 1981 Aug; 33(2):175-82. PubMed ID: 6791951 [No Abstract] [Full Text] [Related]
29. Role of aldose reductase in the development of diabetes-associated complications. Kador PF, Kinoshita JH. Am J Med; 1985 Nov 15; 79(5A):8-12. PubMed ID: 3934965 [Abstract] [Full Text] [Related]
30. Aldose reductase expression in human diabetic retina and retinal pigment epithelium. Vinores SA, Campochiaro PA, Williams EH, May EE, Green WR, Sorenson RL. Diabetes; 1988 Dec 15; 37(12):1658-64. PubMed ID: 3142801 [Abstract] [Full Text] [Related]
31. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications. Saraswat M, Muthenna P, Suryanarayana P, Petrash JM, Reddy GB. Asia Pac J Clin Nutr; 2008 Dec 15; 17(4):558-65. PubMed ID: 19114390 [Abstract] [Full Text] [Related]
32. Differences in the susceptibility of various aldose reductases to inhibition. II. Kador PF, Kinoshita JH, Tung WH, Chylack LT. Invest Ophthalmol Vis Sci; 1980 Aug 15; 19(8):980-2. PubMed ID: 6773903 [Abstract] [Full Text] [Related]
33. Immunoquantitation of aldose reductase in human tissues. Grimshaw CE, Mathur EJ. Anal Biochem; 1989 Jan 15; 176(1):66-71. PubMed ID: 2496622 [Abstract] [Full Text] [Related]
34. Human liver 6-pyruvoyl tetrahydropterin reductase is biochemically and immunologically indistinguishable from aldose reductase. Steinerstauch P, Wermuth B, Leimbacher W, Curtius HC. Biochem Biophys Res Commun; 1989 Nov 15; 164(3):1130-6. PubMed ID: 2511841 [Abstract] [Full Text] [Related]
35. [What is the etiology of diabetic retinopathy?]. Wiedemann P. Ophthalmologe; 1993 Oct 15; 90(5):426-33. PubMed ID: 8219625 [Abstract] [Full Text] [Related]
36. [Ocular microangiopathy in humans]. Chauvaud D. Therapie; 1997 Oct 15; 52(5):453-6. PubMed ID: 9501574 [Abstract] [Full Text] [Related]
37. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase. Jedziniak JA, Chylack LT, Cheng HM, Gillis MK, Kalustian AA, Tung WH. Invest Ophthalmol Vis Sci; 1981 Mar 15; 20(3):314-26. PubMed ID: 6782033 [Abstract] [Full Text] [Related]
38. Lens aldose reductase in diabetic and galactosemic cataracts. Parmar NS, Ghosh MN. Indian J Physiol Pharmacol; 1981 Mar 15; 25(3):193-200. PubMed ID: 6795119 [No Abstract] [Full Text] [Related]
39. On the pathogenesis of diabetic retinopathy. Frank RN. Ophthalmology; 1984 Jun 15; 91(6):626-34. PubMed ID: 6205341 [Abstract] [Full Text] [Related]
40. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin. Maragoudakis ME, Wasvary J, Hankin H, Gargiulo P. Mol Pharmacol; 1984 May 15; 25(3):425-30. PubMed ID: 6427599 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]